Hepatology 65 , 950968 (2017)
A Swedish nationwide study of 227,000 people with alcohol use disorder found that those taking GLP-1 drugs had 36% lower risk of alcohol-related hospitalizations
But still no FDA approval and no Phase III trial data
Central to this axis is the gut microbiota, which plays a pivotal role in maintaining homeostasis across the gastrointestinal, neurological, and renal systems
The Ipamorelin CJC-1295 No DAC Pre-mixed Pen may be easily refilled with pre-mixed cartridges to continue your research
Reviewed by Gabriel Alizaidy, MD, MS Disclaimer: The contents of this article, including, but not limited to, text, graphics, images, and other information, is for information purposes only and does not constitute medical advice